Bepotastine Tablets 10mg

Bepotastine 10mg tablets — a second-generation H1 antihistamine for allergic rhinitis, urticaria and pruritus associated with skin diseases.

Bepotastine Tablets 10mg product packaging
Tablets

Bepotastine Tablets 10mg

Bepotastine 10mg tablets — a second-generation H1 antihistamine for allergic rhinitis, urticaria and pruritus associated with skin diseases. GMP manufactured by Artemisine Medicines Technology with complete batch documentation (COA, COPP, DMF, CTD dossiers) for regulated and emerging markets.

Product NameBepotastine Tablets 10mg
Dosage FormTablets
Strength10 mg
StandardsBP / ENTERPRISE
Packing10×2 blister (20 tablets per box)
DocumentsCOA, COPP, DMF, CTD Dossiers
MOQContact us for MOQ and current stock
Request Quotation › ← Back to Tablets
WHO Prescribing Guidance

Indications · Administration · Dosage · Precautions

Reference information summarised from WHO prescribing guidance. Expand each item below — clinical use must always follow the locally approved product insert.

🎯Indications▾
Treatment of allergic rhinitis, urticaria, and pruritus associated with skin diseases (eczema/dermatitis, prurigo). Second-generation H1-antihistamines are recommended as first-line oral therapy in WHO-aligned urticaria and allergic rhinitis guidance.
💧Administration▾
Oral, twice daily, with or without food.
⚖️Dosage▾
Adults: 10 mg twice daily. Dose reduction recommended in renal impairment.
⚠️Precautions & Warnings▾
May cause drowsiness — patients should not drive or operate machinery if affected. Adjust dose in renal impairment. Caution in elderly patients.

Reference: WHO Model Formulary / WHO Model List of Essential Medicines. For professional reference only — clinical use must follow the locally approved product insert and national treatment guidelines.

Why Order From Us

Factory Direct. Fully Documented.

🛡️

GMP Quality

Full batch testing and quality traceability under standard GMP workshops.

🚢

Fast Delivery

Sufficient stock on regular items, familiar with export logistics to 50+ countries.

📑

Registration Support

COA, DMF, dossier and legalization documents for your market registration.

FAQ

Bepotastine Tablets 10mg — Frequently Asked Questions

Which documents are provided for Bepotastine Tablets 10mg registration?

Every batch of Bepotastine Tablets 10mg ships with a Certificate of Analysis (COA). For market registration we provide COPP, DMF and CTD-format dossiers, plus legalisation support where your authority requires it.

What is the MOQ and lead time for Bepotastine Tablets 10mg?

MOQ and lead time for Bepotastine Tablets 10mg depend on strength, packaging and destination market. Send us your target market and annual volume — our export team confirms current stock, MOQ and lead time within 24 hours.

Do you support OEM / private label?

Yes. We offer OEM packaging and private-label production for Bepotastine Tablets 10mg, subject to the regulatory requirements of the destination market.

Which markets have you exported tablets products to?

We have supplied tablets products to 50+ countries across Africa, Southeast Asia, Latin America and the Middle East, with experience in ministry-of-health registration and international tenders.

How is the quality of Bepotastine Tablets 10mg controlled?

Bepotastine Tablets 10mg is produced in China-GMP workshops (site re-inspected and passed in 2026), released only after full QC testing against BP / enterprise standards, with retained samples kept for one year beyond the product's expiry date.

Ask About This Product ›
✎ 💬 ↑
👋 Hi! I'm Care, your product guide. Tap me to ask about our medicines & APIs. ×
Care - product guide assistant